A survey was used to collect anonymous cross-sectional data on demographics, exercise habits, and use of creatine and other supplements by exercisers in civilian (C) and military (M) health clubs. M (n = 133) reported more aerobic training and less use of creatine and protein supplements than C(n = 96, p < .05). Supplement users (SU, n = 194) and nonusers (SNU, n = 35) engaged in similar frequency and duration of aerobic exercise, as well as number of resistance exercise repetitions, but SU completed more sets for each resistance exercise (x̄ ± SE, 5 ± 1) than SNU (3 ± 1, p ≤ .05). Significant (p ≤ .05) associations were observed between SU and resistance training goal of strength (as opposed to endurance), as well as greater frequency of resistance training. Male gender, resistance training goal of strength, lower frequency and duration of aerobic training, and use of protein, ß-hydroxy-ß-methyl butyrate, and androstenedi-one/dehydroepiandrosterone supplements were all associated with creatine use (p < .05). For creatine users, the dose and length of creatine supplementation was 12.2±2.7g•day·1 for 40 ± 5 weeks. Popular magazines were the primary source of information on creatine (69%) compared to physicians (14%) or dietitians (10%, p ≤ .0001). This study underscores two potential public health concerns: (a) reliance on popular media rather than allied-health professionals for information on creatine, and (b) use of creatine, a popular supplement with unknown long-term effects, in combination with other anabolic supplements of questionable efficacy and/or safety.
Heather L. Sheppard, Sneha M. Raichada, Kellie M. Kouri, Lena Stenson-Bar-Maor and J. David Branch
Megan E. Anderson, Clinton R. Bruce, Steve F. Fraser, Nigel K. Stepto, Rudi Klein, William G. Hopkins and John A. Hawley
Eight competitive oarswomen (age, 22 ± 3 years; mass, 64.4 ± 3.8 kg) performed three simulated 2,000-m time trials on a rowing ergometer. The trials, which were preceded by a 24-hour dietary and training control and 72 hours of caffeine abstinence, were condueted 1 hour after ingesting caffeine (6 or 9 mg kg ’ body mass) or placebo. Plasma free fatty acid concentrations before exercise were higher with caffeine than placebo (0.67 ± 0.34 vs. 0.72 ± 0.36 vs. 0.30±0.10 mM for 6 and 9 mg · kg−1; caffeine and placebo, respectively; p <.05). Performance lime improved 0.7% (95% confidence interval [Cf] 0 to 1.5%) with 6 mg kg−1 caffeine and 1.3$ (95% CI 0.5 to 2.0%) with 9 mg · kg−1 caffeine. The first 500 m of the 2,000 m was faster with the higher caffeine dose compared with placebo or the lower dose (1.53 ± 0.52 vs. 1.55 ± 0.62 and 1.56 ± 0.43 min; p = .02). We concluded that caffeine produces a worthwhile enhancement of performance in a controlled laboratory setting, primarily by improving the first 500 m of a 2,000-m row.
Ian P. Snider, Terry L. Bazzarre, Scott D. Murdoch and Allan Goldfarb
This study examined the effects of the Coenzyme Athletic Performance System (CAPS) on endurance performance to exhaustion. CAPS contains 100 mg coenzyme Q10,500 mg cytochrome C, 100 mg inosine, and 200 IU vitamin E. Eleven highly trained male triathletes were given three daily doses of either CAPS or placebo (dicalcium phosphate) for two 4-week periods using a double-blind crossover design. A 4-week washout period separated the two treatment periods. An exhaustive performance test, consisting of 90 minutes of running on a treadmill (70%
Scott A. Conger, Gordon L. Warren, Michelle A. Hardy and Mindy L. Millard-Stafford
Carbohydrate (CHO) and caffeine (CAF) both improve endurance performance.
To determine by systematic literature review coupled with meta-analysis whether CAF ingested with CHO (CHO+CAF) improves endurance performance more than CHO alone.
Databases were searched using the keywords caffeine, endurance, exercise, carbohydrate, and performance. Criteria for inclusion were studies that used human subjects performing an endurance-exercise performance task and included both a CHO and CHO+CAF condition. Effect sizes (ESs) were calculated as the standardized mean difference.
Twenty-one studies met the criteria for analysis. ESs for individual studies ranged from –0.08 (trivial effect favoring CHO) to 1.01 (large effect favoring CHO+CAF). The overall ES equaled 0.26 (95% CI 0.15–0.38, p < .001), indicating that CHO+CAF provides a small but significant performance benefit over CHO. ES was not significantly (p > .05) related to CAF dose, exercise duration, or performance-assessment method. To determine whether ES of CHO+CAF vs. CHO was different than CAF compared with water (placebo), a subgroup meta-analysis compared 36 CAF vs. placebo studies against the 21 CHO+CAF vs. CHO studies. The overall ES for the former group of studies (ES = 0.51, 95% CI 0.40–0.61) was nearly 2-fold greater than in CHO+CAF vs. CHO studies (p = .006).
CHO+CAF ingestion provides a significant but small effect to improve endurance performance compared with CHO alone. However, the magnitude of the performance benefit that CAF provides is less when added to CHO than when added to placebo.
Reduction of body stores of carbohydrate and blood glucose is related to the perception of fatigue and the inability to maintain high-quality performance. This has been clearly shown with aerobic, endurance events of moderate intensity of over 90 min duration. Carbohydrate intake may also have relevance for athletes involved in short, high-intensity events, especially if body weight control is an issue. Prevention of carbohydrate depletion begins with a high-carbohydrate training diet of about 60-70% carbohydrate. If possible, carbohydrate beverages should be consumed during the event at the rate of 30-70 g/hr to reduce the chance of body carbohydrate depletion. Finally, replacement of body carbohydrate stores can be achieved most rapidly if 40-60 g of carbohydrate is consumed as soon as possible after the exercise and at repeating 1-hr intervals for at least 5 hr after the event.
Kathleen Woolf, Wendy K. Bidwell and Amanda G. Carlson
The study examined caffeine (5 mg/kg body weight) vs. placebo during anaerobic exercise. Eighteen male athletes (24.1 ± 5.8 yr; BMI 26.4 ± 2.2 kg/m2) completed a leg press, chest press, and Wingate test. During the caffeine trial, more total weight was lifted with the chest press, and a greater peak power was obtained during the Wingate test. No differences were observed between treatments for the leg press and average power, minimum power, and power drop (Wingate test). There was a significant treatment main effect found for postexercise glucose and insulin concentrations; higher concentrations were found in the caffeine trial. A significant interaction effect (treatment and time) was found for cortisol and glucose concentrations; both increased with caffeine and decreased with placebo. Postexercise systolic blood pressure was significantly higher during the caffeine trial. No differences were found between treatments for serum free-fatty-acid concentrations, plasma lactate concentrations, serum cortisol concentrations, heart rate, and rating of perceived exertion. Thus, a moderate dose of caffeine resulted in more total weight lifted for the chest press and a greater peak power attained during the Wingate test in competitive athletes.
Matthew S. Ganio, Jennifer F. Klau, Elaine C. Lee, Susan W. Yeargin, Brendon P. McDermott, Maxime Buyckx, Carl M. Maresh and Lawrence E. Armstrong
The purpose of this study was to compare the effects of a carbohydrate-electrolyte plus caffeine, carnitine, taurine, and B vitamins solution (CE+) and a carbohydrate-electrolyte-only solution (CE) vs. a placebo solution (PLA) on cycling performance and maximal voluntary contraction (MVC). In a randomized, double-blind, crossover, repeated-measures design, 14 male cyclists (M ± SD age 27 ± 6 yr, VO2max 60.4 ± 6.8 ml · kg−1 · min−1) cycled for 120 min submaximally (alternating 61% ± 5% and 75% ± 5% VO2max) and then completed a 15-min performance trial (PT). Participants ingested CE+, CE, or PLA before (6 ml/kg) and every 15 min during exercise (3 ml/kg). MVC was measured as a single-leg isometric extension (70° knee flexion) before (pre) and after (post) exercise. Rating of perceived exertion (RPE) was measured throughout. Total work accumulated (KJ) during PT was greater (p < .05) in CE+ (233 ± 34) than PLA (205 ± 52) but not in CE (225 ± 39) vs. PLA. MVC (N) declined (p < .001) from pre to post in PLA (988 ± 213 to 851 ± 191) and CE (970 ± 172 to 870 ± 163) but not in CE+ (953 ± 171 to 904 ± 208). At Minutes 60, 90, 105, and 120 RPE was lower in CE+ (14 ± 2, 14 ± 2, 12 ± 1, 15 ± 2) than in PLA (14 ± 2, 15 ± 2, 14 ± 2, 16 ± 2; p < .001). CE+ resulted in greater total work than PLA. CE+, but not PLA or CE, attenuated pre-to-post MVC declines. Performance increases during CE+ may have been influenced by lower RPE and greater preservation of leg strength during exercise in part as a result of the hypothesized effects of CE+ on the central nervous system and skeletal muscle.
Katherine T. Oberlin-Brown, Rodney Siegel, Andrew E. Kilding and Paul B. Laursen
The oral presence of carbohydrate (CHO) and caffeine (CAF) may independently enhance exercise performance, but their influence on performance during prolonged exercise is less known.
To determine the independent and combined effects of CHO and CAF administered in chewing gum during a cycling time trial (TT) after prolonged exercise.
Eleven male cyclists (32.2 ± 7.5 y, 74.3 ± 6.8 kg, 60.2 ± 4.0 mL · kg–1 · min–1 V˙O2peak) performed 4 experimental trials consisting of 90-min constant-load cycling at 80% of their second ventilatory threshold (207 ± 30 W), followed immediately by a 20-km TT. Under double-blinded conditions, cyclists received placebo (PLA), CHO, CAF, or a combined CHO+CAF chewing gum at 0-, 5-, 10-, and 15-km points of the TT.
Overall TT performance was similar across experimental and PLA trials (%mean difference ± 90%CL 0.2% ± 2.0%, 0.4% ± 2.2%, 0.1% ± 1.8% for CHO, CAF, and CHO+CAF). Compared with PLA, mean power output tended to be higher in the first 2 quarters of the TT with CHO (1.6% ± 3.1% and 0.8% ± 2.0%) and was substantially improved in the last 2 quarters during CAF and CHO+CAF trials (4.2% ± 3.0% and 2.0% ± 1.8%). There were no differences in average heart rate (ES <0.2) and only small changes in blood glucose (ES 0.2), which were unrelated to performance. Blood lactate was substantially higher post-TT for CAF and CHO+CAF (ES >0.6).
After prolonged constant-load cycling, the oral presence of CHO and CAF in chewing gum, independently or in combination, did not improve overall performance but did influence pacing.
Peter D. Kupcis, Gary J. Slater, Cathryn L. Pruscino and Justin G. Kemp
The effect of sodium bicarbonate (NaHCO3) ingestion on prerace hydration status and on 2000 m ergometer performance in elite lightweight rowers was examined using a randomized, cross-over, double-blinded design.
To simulate body mass (BM) management strategies common to lightweight rowing, oarsmen reduced BM by approx. 4% in the 24 h preceding the trials, and, in the 2 h before performance, undertook nutritional recovery consisting of mean 43.2 kJ/kg, 2.2 g of CHO per kilogram, 31.8 mg of Na+ per kilogram, 24.3 mL of H2O per kilogram, and NaHCO3 (0.3 g of NaHCO3 per kilogram BM) or placebo (PL; 0.15 g of corn flour per kilogram BM) at 70 to 90 min before racing.
At 25 min before performance, NaHCO3 had increased blood pH (7.48 ± 0.02 vs PL: 7.41 ± 0.03, P = .005) and bicarbonate concentrations (29.1 ± 1.8 vs PL: 23.9 ± 1.6 mmol/L, P < .001), whereas BM, urine specific gravity, and plasma volume changes were similar between trials. Rowing ergometer times were similar between trials (NaHCO3: 397.8 ± 12.6; PL: 398.6 ± 13.8 s, P = .417), whereas posttest bicarbonate (11.6 ± 2.3 vs 9.4 ± 1.8 mmol/L, P = .003) and lactate concentration increases (13.4 ± 1.7 vs 11.9 ± 1.9 mmol/L, P = .001) were greater with NaHCO3.
Sodium bicarbonate did not further enhance rehydration or performance in lightweight rowers when undertaking recommended post-weigh-in nutritional recovery strategies.